• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗雄激素对LNCaP人前列腺肿瘤细胞生长、表皮生长因子受体水平及酸性磷酸酶分泌的刺激作用。

Stimulatory effects of antiandrogens on LNCaP human prostate tumor cell growth, EGF-receptor level and acid phosphatase secretion.

作者信息

Schuurmans A L, Bolt J, Veldscholte J, Mulder E

机构信息

Department of Biochemistry, Erasmus University Rotterdam, The Netherlands.

出版信息

J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):849-53. doi: 10.1016/0960-0760(90)90431-j.

DOI:10.1016/0960-0760(90)90431-j
PMID:2149505
Abstract

LNCaP cells (derived from a lymph node carcinoma of the human prostate) show androgen responsive growth. Progestagens, estradiol and antiandrogens competed with androgens for binding to the androgen receptor in the cells to a higher extent than in other androgen-sensitive systems. Optimal growth (3-4 fold increase in DNA content of 6 day cell cultures vs controls) was observed after addition of the synthetic androgen R1881 (0.1 nM). Both steroidal and non-steroidal antiandrogens did not suppress the androgen responsive growth. At a concentration of 10 nM cyproterone acetate or 100 nM RU 23908, growth was even stimulated to an extent comparable to that observed after addition of androgen. Cyproterone acetate and RU 23908 also increased the number of epidermal growth factor receptors expressed at the cell surface to a comparable level as did the androgen. Like androgens, cyproterone acetate, RU 23908 or estradiol stimulated the secretion per cell of prostate specific acid phosphatase in the culture fluid. In conclusion, antiandrogens can exert striking stimulatory effects on the proliferation of LNCaP cells probably due to a defective androgen receptor system. It is discussed that comparable changes in the specificity of the androgen receptor in prostate cancer cells may give these cells an advantage in growth rate and may contribute to development of tumors characterized as hormone independent.

摘要

LNCaP细胞(源自人类前列腺的淋巴结癌)呈现雄激素反应性生长。孕激素、雌二醇和抗雄激素与雄激素竞争结合细胞内的雄激素受体,其竞争程度高于其他雄激素敏感系统。添加合成雄激素R1881(0.1 nM)后观察到最佳生长状态(6天细胞培养物的DNA含量比对照增加3 - 4倍)。甾体类和非甾体类抗雄激素均未抑制雄激素反应性生长。在醋酸环丙孕酮浓度为10 nM或RU 23908浓度为100 nM时,生长甚至被刺激到与添加雄激素后相当的程度。醋酸环丙孕酮和RU 23908还使细胞表面表达的表皮生长因子受体数量增加到与雄激素相当的水平。与雄激素一样,醋酸环丙孕酮、RU 23908或雌二醇刺激培养液中每个细胞分泌前列腺特异性酸性磷酸酶。总之,抗雄激素可能由于雄激素受体系统缺陷而对LNCaP细胞的增殖产生显著的刺激作用。讨论了前列腺癌细胞中雄激素受体特异性的类似变化可能使这些细胞在生长速度上具有优势,并可能有助于发展为激素非依赖性肿瘤。

相似文献

1
Stimulatory effects of antiandrogens on LNCaP human prostate tumor cell growth, EGF-receptor level and acid phosphatase secretion.抗雄激素对LNCaP人前列腺肿瘤细胞生长、表皮生长因子受体水平及酸性磷酸酶分泌的刺激作用。
J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):849-53. doi: 10.1016/0960-0760(90)90431-j.
2
Antiandrogens inhibit human androgen receptor-dependent gene transcription activation in the human prostate cancer cells LNCaP.抗雄激素可抑制人前列腺癌细胞LNCaP中依赖人雄激素受体的基因转录激活。
Prostate. 1994 Apr;24(4):176-86. doi: 10.1002/pros.2990240403.
3
Androgen-dependent growth regulation of and release of specific protein(s) by the androgen receptor containing human prostate tumor cell line LNCaP.含雄激素受体的人前列腺肿瘤细胞系LNCaP对特定蛋白质的雄激素依赖性生长调节及释放
Prostate. 1986;9(3):247-59. doi: 10.1002/pros.2990090305.
4
Control of the proliferation of prostate cancer cells by an androgen and two antiandrogens. Cell specific sets of responses.雄激素和两种抗雄激素对前列腺癌细胞增殖的控制。细胞特异性反应组。
J Steroid Biochem Mol Biol. 1998 Aug;66(4):235-40. doi: 10.1016/s0960-0760(98)00038-7.
5
Aberrant response in vitro of hormone-responsive prostate cancer cells to antiandrogens.
Prostate. 1989;14(2):103-15. doi: 10.1002/pros.2990140204.
6
The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens.
J Steroid Biochem Mol Biol. 1992 Mar;41(3-8):665-9. doi: 10.1016/0960-0760(92)90401-4.
7
Androgens stimulate both growth rate and epidermal growth factor receptor activity of the human prostate tumor cell LNCaP.雄激素可刺激人前列腺肿瘤细胞LNCaP的生长速率和表皮生长因子受体活性。
Prostate. 1988;12(1):55-63. doi: 10.1002/pros.2990120108.
8
Inhibition of androgen binding in human foreskin fibroblasts by antiandrogens.
Steroids. 1981 Jun;37(6):635-48. doi: 10.1016/s0039-128x(81)90173-2.
9
Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system.在一个新的模型系统中,雄激素受体拮抗剂比卡鲁胺向激动剂的转变与前列腺肿瘤进展相关。
Br J Cancer. 1999 Sep;81(2):242-51. doi: 10.1038/sj.bjc.6690684.
10
The kinetics of antiandrogens in humans.
Prog Clin Biol Res. 1987;243A:341-50.

引用本文的文献

1
Nilutamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in prostate cancer.尼鲁米特。对其药效学、药代动力学特性及在前列腺癌治疗中的疗效的综述。
Drugs Aging. 1993 Jan-Feb;3(1):9-25. doi: 10.2165/00002512-199303010-00002.
2
A model to describe how a point mutation of the estrogen receptor alters the structure-function relationship of antiestrogens.
Breast Cancer Res Treat. 1993;26(2):139-47. doi: 10.1007/BF00689687.
3
The estrogen receptor from a tamoxifen stimulated MCF-7 tumor variant contains a point mutation in the ligand binding domain.来自他莫昔芬刺激的MCF-7肿瘤变体的雌激素受体在配体结合域中含有一个点突变。
Breast Cancer Res Treat. 1994;31(1):129-38. doi: 10.1007/BF00689683.
4
William L. McGuire Memorial Symposium. Drug resistance to tamoxifen during breast cancer therapy.威廉·L·麦圭尔纪念研讨会。乳腺癌治疗期间对他莫昔芬的耐药性。
Breast Cancer Res Treat. 1993;27(1-2):27-40. doi: 10.1007/BF00683191.